BioM's article about the Bavarian biotechnology sector

Philip Gregory from bluebird bio about "Therapies of the future" at the BioM-BioEntrepreneurship Summit

This is the title of Philip Gregory's key note at the BioEn­tre­pren­eur­ship Sum­mit on 10/11. Octo­ber in Mu­nich. Philip D. Gregory has…

Immunotherapy. ImmPact Bavaria goes on! Join us!

Im­mPact Bav­aria, the con­sor­ti­um for in­nov­at­ive im­mun­o­ther­apy moved its first steps in Octo­ber 2016. Al­most 1 year after the…

Future X Healthcare

The event has been ini­ti­ated by Roche to con­nect key in­nov­a­tion drivers in health­care for an open and in­spir­ing ex­change of ideas,…

Immunotherapy: ImmPact Bavaria at the FORUM Science & Health 2017

Im­mPact Bav­aria, the Bav­ari­an ZIM-net­work of in­nov­at­ive im­mun­o­ther­apy, will at­tend on July 5-6th the FORUM Science & Health…

Biotechnology Network BioM celebrates its 20th anniversary

With 225 com­pan­ies and five to ten star­tups foun­ded each year, Bav­aria is the lead­ing cen­ter for Ger­man bi­o­tech­no­logy. …

Startups can now apply for EIT Health Accelerator 2017

We are pleased to an­nounce that star­tups can now apply for EIT Health Ac­cel­er­at­or 2017 pro­grams until 31 March 2017. Start-ups can…

Pieris Pharmaceuticals and Servier Forge Strategic Immuno-oncology Co-development Alliance

Foun­ded in Fre­is­ing (near Mu­nich), co-loc­ated in Bo­ston (USA), NASDAQ-lis­ted Pier­is joins forces in im­muno-on­co­logy drug…

Recent developments in personalized medicine

On Novem­ber 29 and 30, 230 ex­perts from all over Europe par­ti­cip­ated in the 6th Mu­nich Bio­mark­er Con­fer­ence in Mu­nich. The…

Strong immuno start in Munich: iOmx hits the ground running

Im­muno-on­co­logy star­tup iOmx Thera­peut­ics has raised 40 mil­lion Euro in its first round of fin­an­cing.

Medigene (Munich) launches a billion-dollar collaboration with bluebird bio

"We are de­lighted to col­lab­or­ate with blue­bird bio, a lead­er in the field of cell and gene ther­apy, in­clud­ing can­cer…




Publish press release

Would you like to enter or update data?
Request login data

Dr. Georg Kääb
Dr. Georg Kääb

Corporate Communications, Managing Director Bavarian Biotech Cluster